Seu carrinho está vazio
Comece a adicionar peptídeos de pesquisa ao seu carrinho.
VOCÊ TAMBÉM PODE GOSTAR
The ORYN peptide pen is a precision dial-a-dose injection device manufactured in a WHO/EU-GMP certified facility in South Korea. Every pen is engineered to deliver the same mechanical dose per click regardless of cartridge fill level, refrigeration cycle, or researcher technique. Here is exactly how.
Factory-calibrated ratcheting screw-gear
Each click advances the internal lead-screw a fixed fraction of a turn, pushing the plunger a precisely machined distance through the cartridge. The same click always delivers the same volume regardless of cartridge fill level.
<2% per click
Mechanical variance is bounded by the screw pitch tolerance (±0.01 mm) and the plunger seal friction (±0.4%), independently verified on a Bosch-type injection test rig. A traditional syringe-from-vial workflow averages ±8–12% variance depending on researcher technique.
3.0 mL sealed glass
Type I borosilicate glass cartridge with a chlorobutyl rubber plunger and an aluminium seal, sterilised via gamma irradiation after fill. The sealed design prevents the oxygen ingress that oxidises peptide-bond disulphide bridges in open vials.
0.22 μm filtration + gamma sterilisation
The peptide solution is passed through a 0.22 μm Millipore PES membrane during fill (removes bacteria and spores), then the sealed cartridge is gamma-irradiated at 15–25 kGy to kill any residual bioburden without affecting peptide conformation.
Standard Luer-style pen needles (29G–34G)
Compatible with standard insulin pen needles sold globally (e.g. BD Micro-Fine, NovoFine, Ypsomed mylife Clickfine). Each attachment advances a fresh sterile needle into the rubber seal — no needle re-use, no contamination carry-over.
24 months unopened, 30 days in use
At 2–8 °C refrigerated. Once the seal is pierced for first use, peptide stability data from HPLC studies shows <5% degradation over 30 days when the pen is returned to the fridge between uses.
Refrigerated 2–8 °C
Shipped in insulated packaging with cold packs to maintain temperature in transit. Do not freeze: freezing can crystallise the peptide solution and damage the cartridge seal. Room-temperature excursions up to 25 °C for 24 hours are tolerated.
0.5–2.0 mg per click (product-dependent)
Each pen is pre-configured for its product's research dose range. BPC-157 and TB-500 pens deliver smaller clicks (0.25–0.5 mg), while MediT Tirzepatide and NovaDose NAD+ have larger clicks (1.0–2.0 mg) to match typical research protocols.
GMP + ISO 7 cleanroom manufactured
Produced in a WHO/EU-GMP certified facility in South Korea that also manufactures commercial diabetic-care pens. ISO 14644 Class 7 cleanroom ensures <352,000 particles ≥0.5 μm per cubic metre during fill.
Type I glass, chlorobutyl, stainless steel
Every surface touching the peptide solution is USP Class VI and EU Ph. Eur. 3.1 / 3.2 compliant. No silicone oil migration, no latex, no plasticiser leaching.
Traditional vial-based peptide supply uses a rubber stopper that a researcher pierces with a syringe needle every time a dose is drawn. Each puncture introduces a tiny amount of ambient oxygen into the vial headspace, and oxygen is the primary driver of peptide degradation: it oxidises disulphide bridges, opens peptide rings, and generates side-chain carbonyl products that show up as secondary peaks on an HPLC trace.
The ORYN pen cartridge solves this by sealing the solution inside a Type I borosilicate glass tube with a single chlorobutyl rubber plunger that only moves inward. The plunger never retracts, so oxygen never backfills. The result: our in-house HPLC stability data shows <5% peptide degradation over the full 30-day in-use window, compared with 15–40% degradation typical of an open vial over 14 days.
The second advantage is sterility. ORYN cartridges are 0.22 μm-filtered during fill (which removes bacteria and spores) and then gamma-irradiated at 15–25 kGy in their final packaging. Gamma sterilisation is the gold standard for medical-device terminal sterilisation because it penetrates the packaging without leaving chemical residues. Open-vial workflows rely on the researcher's aseptic technique for sterility — a well-documented source of contamination in the literature.
Finally, the mechanical dose calibration. The ratcheting screw-gear inside every ORYN pen is machined to ±0.01 mm tolerance, meaning the plunger travel per click is bounded by mechanical precision rather than researcher skill. Independent verification on a Bosch-type injection test rig shows <2% dose variance across 1,000+ simulated injections. A hand-drawn syringe dose averages ±8–12% variance — a 4–6× improvement in reproducibility.
Pen vs Vial
12-category comparison of peptide pens vs traditional injection vials: dosing accuracy, contamination, reconstitution, shelf life, training, cost per dose, research auditability.
How to Use
Complete 9-step guide to using an ORYN peptide pen: removal from fridge, cartridge inspection, needle attachment, priming, dialling, injection and disposal. Research use only.
Needles
ORYN peptide pens accept standard Luer-style insulin pen needles in 29G–34G, 4–8 mm. Full compatibility table for BD Micro-Fine, NovoFine, Ypsomed Clickfine, Terumo, Owen Mumford.
Storage
Keep ORYN peptide pens at 2–8 °C. Never freeze. 24 months unopened, 30 days in use. Room-temperature excursions and travel guidance for research fieldwork.
FAQ
Full FAQ for ORYN peptide pens: technology, accuracy, pen vs vial, needle choice, storage, freezing, travel, sharps disposal, batch traceability, click increments.
Safety
Safety protocol for ORYN peptide pens: single-use needles, approved sharps disposal, contamination avoidance, and the research-only boundary that ORYN never crosses.
